Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early Alendronate for Bone Loss After Hip Fracture
NCT00346190Phase 3Unknown
- Sponsor
- McGill University Health Centre
- Start
- Jan 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of alendronate in osteoporosis, sponsored by McGill University Health Centre. Status: unknown.
02
Drugs
alendronate
03
Conditions
osteoporosis
Beyond the preview
Go deeper on NCT00346190.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00346190.